Treatment algorithms of relapsing multiple sclerosis: an exploration based on the available disease-modifying therapies in China

Pathology of multiple sclerosis and mechanism of available disease-modifying therapies in China. IFN-β could affect multiple levels of cellular functions to increase the levels of anti-inflammatory agents and reduce the levels of pro-inflammatory cytokines. GA is a noninterferon immunomodulator, which has a similar effect as that of IFN-β on multiple levels of cellular functions. Teriflunomide is a selective, non-competitive, reversible inhibitor of dihydro-orotate dehydrogenase (DHODH), which prevents the proliferation of T- and B-lymphocytes in the periphery. DMF is defined as the Nrf2 activator, which could further activate Keap1/Nrf2/ARE signaling pathway to extert its anti-inflammatory and neuroprotective effects. S1PRMs have a dual action on S1PRs as the pharmacological antagonists or agonists to prevent the lymphocyte exit into circulation from secondary lymphoid organs. Anti-CD20s could directly target CD20+ B cells to deplete B cells.Letters in red: DMTs approved in China; Letters in blue: DMTs not approved in China.Anti-CD20s, Anti-CD20 monoclonal antibodies; APC, Antigen-presenting cells; B, B cells; BBB, Blood–brain barrier; Breg, Regulatory B cells; DC, Dendritic cells; DMF, Dimethyl fumarate; DMT, disease-modifying therapy; EB virus, Epstein–Barr virus; GA, Glatiramer acetate; IFN, Interferon; IL, Interleukin; S1P, Sphingosine-1-phosphate; S1PRMs, S1P receptor modulators; T, T cells; Teff, Effector T cells; TGF, Transforming growth factor; Th, T helper cells.
Treatment algorithms of relapsing multiple sclerosis: an exploration based on the available disease-modifying therapies in China

Publication

Treatment algorithms of relapsing multiple sclerosis: an exploration based on the available disease-modifying therapies in China. (2024) Jun Guo, et al. Ther Adv Neurol Disord. 2024;17:17562864241239117. Figure: F1.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID

Chemical mentions

Word Match MeSH Name ChEBI

Disease mentions

Word Match MeSH Name DOID